PUBLIC COMPANY
save$IRONDisc Medicine, Inc.
$IRON83.20+4.13%Watertown, MA, USupdated 19d ago
community read0 votes
pipeline
3
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
3Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
- phase3HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP
- phase2Study of DISC-0974-201 in Participants With IBD and Anemia
- phase3Study of Bitopertin in Participants With EPP or XLP (APOLLO)
- —Expanded Access Program of Bitopertin For Participants With EPP or XLP
- phase1A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- phase1Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia
- phase2A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)
🐶 Hiring Signal
Where Disc Medicine, Inc. is staffing up — a leading indicator of pipeline and commercial priorities.
therapeutic areaHematology 18Rare Disease 1
News
- STAT+: As more doctors consult chatbots, health systems can block them — or buy inAs hundreds of thousands of doctors consult AI chatbots to make care decisions, health systems see new risks to patients' health data.stat · 12d ago
- Top health takeaways from the midterm electionsDemocrats gained control of both chambers of Congress, and doctors and scientists won key seats. Here are the top health takeaways from the midterms.stat · 12d ago
- STAT+: Amid Mass General Brigham layoffs, CEO pens vague letter, stirring staff anxietyA cryptic email sent to Mass General Brigham employees by the health system's CEO is stirring staff anxiety less than two weeks after a round of layoffs.stat · 13d ago
- Politicians have failed to tackle health care affordability. It’s now voters’ rallying cryAs costs surge, voters are embracing more radical solutions to the crisis.stat · 19d ago
- Opinion: Health care needs buyers willing to say no"The industry’s major players have little appetite for change," writes Anthony T. Lo Sasso.stat · 19d ago
- What has actually caused the decline in drug overdose deaths?After years of steep increases, especially amid the pandemic, U.S. overdose deaths decreased 27% in 2024, and preliminary data from 2025 show another meaningful drop.stat · 19d ago
- Have you been impacted by Epic’s actions?STAT is looking to learn, from people with direct knowledge, how Epic's actions impact hospitals' technology choices. Share your story with us.stat · 20d ago
- STAT+: As Epic’s dominance grows, its iron grip is choking innovation in health technologyA STAT investigation found that Epic selectively withholds access to patient data, disadvantaging rival software developers and stymying innovation.stat · 20d ago
- The 4 stages of women’s heart health: New framework for doctors and patientsNew guidance is intended to help girls and women — and their doctors — recognize four distinct phases in heart health.stat · 22d ago
- Disc’s once-spurned rare disease drug to get a second chance at approvalMonths after the FDA rejected its treatment for a rare light-sensitivity disease, the biotech claimed success in a Phase 3 trial and now plans to re-engage regulators.biopharma_dive · 28d ago
Data sources
last refreshed 31m ago
Found something off?
comments(0)
5-min edit window · permanent after that